Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Harrisonia abyssinica
East African shrub used for malaria, skin infections, and gastrointestinal disorders across Kenya, Uganda, and Tanzania.
Harrisonia abyssinica is an East African shrub traditionally used for malaria, skin infections, and gastrointestinal disorders. Its bark and roots contain limonoids (e.g., harrisonin), tannins, flavonoids, and terpenoids, which contribute to antimalarial, antibacterial, anti-inflammatory, and antifungal activities. Evidence is limited to in vitro and preliminary animal studies (evidence level C), supporting its traditional use but requiring further clinical validation.
The antimalarial activity is attributed to limonoids such as harrisonin, which inhibit Plasmodium falciparum growth by disrupting heme detoxification and possibly interfering with the parasite's digestive vacuole. Tannins and flavonoids contribute to antibacterial effects via membrane disruption and enzyme inhibition. Anti-inflammatory actions may involve suppression of pro-inflammatory cytokines (e.g., TNF-α, IL-6) and inhibition of cyclooxygenase (COX) and lipoxygenase (LOX) pathways. Antifungal effects are linked to terpenoid-induced cell wall damage.
East African shrub used for malaria, skin infections, and gastrointestinal disorders across Kenya, Uganda, and Tanzania.
Harrisonia abyssinica is an East African shrub traditionally used for malaria, skin infections, and gastrointestinal disorders. Its bark and roots contain limonoids (e.g., harrisonin), tannins, flavonoids, and terpenoids, which contribute to antimalarial, antibacterial, anti-inflammatory, and antifungal activities. Evidence is limited to in vitro and preliminary animal studies (evidence level C), supporting its traditional use but requiring further clinical validation.
The antimalarial activity is attributed to limonoids such as harrisonin, which inhibit Plasmodium falciparum growth by disrupting heme detoxification and possibly interfering with the parasite's digestive vacuole. Tannins and flavonoids contribute to antibacterial effects via membrane disruption and enzyme inhibition. Anti-inflammatory actions may involve suppression of pro-inflammatory cytokines (e.g., TNF-α, IL-6) and inhibition of cyclooxygenase (COX) and lipoxygenase (LOX) pathways. Antifungal effects are linked to terpenoid-induced cell wall damage.